Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Sorry a bit late! Grrrr! Was busy! Grrrr

$Cogent Biosciences (COGT.US)$ Cogent Biosciences Announces Positive Part 1b Data From SUMMIT Trial Evaluating Bezuclastinib in Patients With Nonadvanced Systemic Mastocytosis
GlobeNewswire· 30 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
9315 Views
Comment
Sign in to post a comment
    4026Followers
    24Following
    58KVisitors
    Follow